Margin recovery in focus as price hikes and Hindupur automation take hold
Q2 FY27 will test whether pricing power and manufacturing efficiency can offset earlier raw-material headwinds. Analyst views are split: some upgraded on margin hopes, others remain cautious on valuation. The key metric: EBITDA expansion as guidance flows through.
The setup: margin recovery, pricing flow-through, and automation gains
Berger Paints enters Q2 FY27 with three tailwinds in motion. First: staggered price hikes (12–13%) announced across product lines are now expected to flow through the full quarter, bolstering gross margins after a Q1 squeezed by raw-material inflation tied to crude oil. Second: the ₹188 Cr, fully automated solvent-based facility in Hindupur commenced production on September 9, adding 36,000 KL/MT capacity and targeting cost efficiencies in southern markets and exports. Third: management guided for double-digit volume growth in FY27, supported by monsoon-driven rural recovery and steady urban demand. The Street's debate now hinges on whether management can deliver 18–19% EBITDA margins in Q2—a step up from Q1's pressure—and sustain momentum into H2.
~₹3,450 Cr
Inline with Q1 FY27 (₹3,584 Cr consol), slight variance from mix and volume growth
18–19%
Price hikes fully reflected; Hindupur automation offsets input cost inflation
Double-digit YoY
Rural momentum (monsoon), industrial pricing, urban steady state
Hindupur live
Facility began commercial production Sep 9; ramp-up visibility in Q2
A strong Q2 print would show revenue +10–12% YoY, EBITDA margins at or above 18% (pricing fully captured, Hindupur contributing), and guidance maintained or raised for full-year FY27 double-digit growth. A weak print would see margins below 17%, volume growth underwhelming, or a cautionary tone on H2 demand or input cost headwinds. Anything signalling margin compression despite the price action or delays in Hindupur ramp-up would weigh on sentiment given the stock's current valuation reset (₹464 vs ATH ₹727, RSI neutral, price below all moving averages).
On track: FY27 guidance trajectory
Q1 FY27 delivered consolidated revenue +12.0% YoY (₹3,583.8 Cr) and PAT +28.6% (₹405.0 Cr), but the PAT figure benefited from Q1 FY26's depressed comparatives. Adjusting for the low base, Q1 showed organic margin resilience. Management reaffirmed double-digit FY27 growth with margin expansion as capacity (Hindupur) and pricing flow through. Full-year guidance remains intact, but Q2 is the litmus test: if pricing and automation don't compress margins despite input inflation, the market will likely reset its 2027 earnings bake, supporting the upgrade thesis some analysts (Geojit at ₹628) have advanced.
Since last quarter: Operationally strong, financially cautious
1 · Hindupur facility live (Sep 9)
Fully automated, solvent-based paint plant commenced commercial production. 36,000 KL/MT capacity addition; first margin benefit expected in Q2 via cost efficiency and southern/export logistics optimization.
2 · Board and management continuity
MD Abhijit Roy reappointed for four years (Jul 1, 2027–Jun 30, 2031). New independent director (Navjeet Singh Sobti) and whole-time director (Amardeep Jain) appointed in Aug. ESG score 60/100 assigned for FY26. Indicates management stability and focus on governance.
3 · Insider activity: Promoter buying
Five promoter-group members acquired shares in early Sep (Rishma Kaur, Kanwardip Singh Dhingra, Jessima Kumar, Anshana Sawhney, Sunaina Kohli). Aggregate stake ~0.008% but signals internal confidence near ₹460–480 levels.
4 · Trading window closure (Oct 1)
Window closed from Oct 1, 2026, and will reopen 48 hours post board meeting (Nov 5). Routine insiders' closure; no unusual flows flagged.
What to watch on result day
1. EBITDA margin print — does it reach or exceed 18%? This is the single metric that will reset the valuation debate. If below 17%, the automation thesis takes a hit. 2. Revenue and volume trajectory — confirm +10% YoY growth; any shortfall vs. management's double-digit FY27 guidance would raise red flags on rural demand or market share loss. 3. Price realization and mix shift — commentary on volume/price split in pricing action. Is volume growing organically, or are price hikes masking slower unit volumes? 4. FY27 guidance reiteration — does management maintain double-digit growth and margin expansion targets? Any downside revision would confirm the Street's caution; an upgrade would validate the Geojit call.
Berger Paints' Q2 FY27 result is fundamentally a margin story. The company has invested in automation (Hindupur), implemented pricing, and navigated raw-material inflation. Street analysts are split on whether the payoff is real, but the upside is there if execution is on plan. The stock's 36% drawdown from ATH and neutral technicals suggest the market is pricing in execution risk; a strong Q2 could shift that calculus. Watch the margin print, volume trend, and full-year guidance restatement.
Berger Paints Q2: margins compress, consol PAT +5% YoY, standalone profit falls 7%
PAT +5.19% YoY · revenue +13.19% · margins compressing · inline vs street
₹3,200.37 Cr
+13.19% YoY
₹217.1 Cr
+5.19% YoY
6.72%
-0.5pp YoY
₹1.86
Berger Paints' consolidated (primary) Q2 FY27 revenue rose 13.2% YoY to ₹3,200.4 Cr, but consolidated PAT grew just 5.2% YoY to ₹217.1 Cr — profit trailing topline growth by roughly 8 percentage points as operating margin (EBITDA/revenue) compressed to 11.6% from 12.5% a year ago. On a standalone basis, the divergence is sharper: revenue grew 11.9% YoY to ₹2,750.1 Cr, yet standalone PAT fell 7.3% YoY to ₹163.3 Cr and standalone EBITDA declined 4.4% YoY, with standalone margin compressing from 12.7% to 10.8%. The gap between the two bases (consolidated profit up, standalone profit down) is explained by stronger performance at the Industrial, Construction Chemical and International subsidiaries plus an ₹8.05 Cr joint-venture profit contribution, both of which flow into the consolidated number but not the standalone one.
Q2 FY-2027 vs prior quarters
Management attributes the margin squeeze to a sharp rise in raw-material costs combined with higher advertising spend behind the newly launched "Rang Bana Rahe" corporate campaign — the two factors management itself cites as the cause of the standalone operating-profit decline. Against its own prior guidance of a 15-17% FY27 operating-margin band (Q1 had come in at 17.4% on favourable seasonal mix), this quarter's 11.6% consolidated OPM is a clear miss, and the H1 FY27 run-rate of 14.4% is still below the guided range. Revenue guidance fared better: management had flagged Q2 growth "slightly ahead of Q1," and consolidated growth of 13.2% did edge past Q1's ~12% YoY pace, so the double-digit revenue growth outlook remains on track even as margins lag.
The stock went into the print at ₹499.85, up 5.6% over the past month of trading.
FY27 double-digit revenue growth expected to sustain; operating margins remain within 15–17% guidance range (Q1 achieved 17.4% on seasonal mix). Q2 revenue growth expected slightly ahead of Q1; volume growth ~7.5–8%, price increases 7.5–8.5%. CapEx ₹600–800 Cr for FY27 (two new factories ramping beyond).
— This quarter: missed
A Zeebiz preview ahead of the print had flagged PAT growth of roughly 5% for the quarter and warned the company would miss its own ~5% "value growth" ambition set after three price hikes since June — the consolidated 5.2% PAT growth landed almost exactly on that estimate (inline), though the standalone 7.3% profit decline represents a miss on the core India decorative-paints business specifically. Within the quarter, the company commenced production at its new Hindupur facility, part of the ₹600-800 Cr FY27 capex plan for two new factories; the trading window closure ahead of results and a handful of sub-0.01% insider stake additions were the only other recorded developments and don't bear on the numbers.
W1
Whether the price hikes management flagged for November restore consolidated OPM toward the 15-17% FY27 guided band, after an 11.6% Q2 and 14.4% H1 run-rate
W2
Standalone (core decorative) PAT trajectory — down 7.3% YoY this quarter — to confirm whether raw-material pressure eases or the standalone/consolidated gap persists
W3
Ramp-up contribution of the newly commissioned Hindupur plant within the ₹600-800 Cr FY27 capex programme
No exceptional items in either quarterly column (the ₹36.81 Cr fire write-off sat in the H1 FY26 and FY26-audited columns only, reversed in Q4 FY26), so raw and adjusted YoY are identical; consolidated NCI is immaterial at ₹0.21 Cr; all figures tie exactly to the company's press release.
Revenue solid, margins crumble — the execution gap widens
Berger delivered 13.2% revenue growth and 5.2% PAT growth, but the quarter masked a sharp margin collapse and working capital deterioration that management's forward guidance doesn't adequately address. The real story is what's NOT working.
₹3,200.4 Cr
+13.2% YoY
₹217.1 Cr
+5.2% YoY; –46.4% QoQ
10.8%
vs 14.4% H1, 15–17% guidance
36.6%
vs 38.1% H1; –150 bps YoY
The headline reads solid: revenue up 13.2%, profit up 5.2%. But dig into the quarter and the story inverts. Berger's EBITDA margin crashed to 10.8% from 14.4% in the first half and sits 4–6 percentage points below the 15–17% guidance management reaffirmed on the call. Profit growth came almost entirely from H1 tailwinds and extraordinary marketing spend; quarter-on-quarter, profit fell 46.4%. Raw material inflation spiked faster than pricing could follow. Inventory ballooned ₹400 crore—booked at peak raw material costs. A ₹22 crore brand campaign (Rangbanara) pulled down operating leverage. Working capital deteriorated sharply. This is not a quarter that validates management's guidance.
Management's key claims — graded
Revenue growth 13.2% consolidated on price and volume mix
Operating margins will be close to 15–17% in Q3 and Q4
Volume growth moderated due to Diwali shift and price-sensitive category de-growth
Gross margin impacted by RM inflation but compression contained
PAT growth 5.2% consolidated H1 meaningful
Revenue and volume claims hold water—the 13.2% YoY print is real and 5.6% H1 volume growth, while below the 7.5–8% guidance, reflects an honest Diwali calendar shift and putty/texture de-growth in a price-sensitive market. But margin guidance has not been corroborated. Q2 EBITDA at 10.8% contradicts the 15–17% band. Gross margin fell 150 bps to 36.6%, and management's framing of compression as "contained" is contradicted by the 360 bp gap between Q2 (10.8%) and guidance (15–17%). PAT growth of 5.2% is also misleading—it's the H1 weighted average; Q2 standalone PAT fell 7.3% and QoQ it cratered 46.4%.
What changed on this call
Volume guidance miss is now explicit. Prior call set 7.5–8% volume growth; H1 actual is 5.6%, Q2 alone 3%. Raw material inflation emerged as a larger headwind than the prior call suggested—management now frames it as a near-term margin drag with recovery contingent on crude oil prices and pricing stickiness. Price realization (6.7% H1) offset volume softness, but the lag between raw material cost inflation and price realization hits gross margin. New products launched (waterproof tile adhesive, decorative panels, Dam Shield) and the Rangbanara Rahe brand campaign represent a strategic shift toward specialty and brand—but the ₹22 crore spend in Q2 alone (extraordinary for a company with ₹217 crore net profit) signals elevated investment cycle ahead. Factory expansion in West Bengal and Orissa is now a confirmed commitment, funded from net cash; timing and ramp are uncertain. Management reaffirmed FY27 double-digit revenue growth and 15–17% margins but qualified margin recovery on October–November price increases and crude oil price stability—both externals beyond management's direct control.
Bull-bear ledger
Revenue growth 13.2% on pricing 6.7% + volume 5.6% — both drivers live
Market leadership and brand heritage (100 years, 2,000+ retail stores)
New products (waterproof adhesive, decorative panels) address specialty upside
Net cash position funds CapEx without dilution; dividend sustainable
Margin guidance (15–17%) not met in Q2 (10.8%); recovery bets on externals
Volume growth decelerating (5.6% H1, 3% Q2 vs. 7.5–8% guidance); demand elasticity emerging
Inventory buildup ₹400 Cr at peak RM prices; working capital deteriorated
Extraordinary ₹22 Cr marketing spend (Rangbanara) with uncertain ROI
Competitive intensity from Asian Paints entry; pricing power constrained
QoQ PAT collapse –46.4% signals high leverage and execution risk
Risks, ranked by how much they should concern a holder
1
High
Management expects 90% margin recovery by November if prices hold. But if crude oil prices spike, demand softens, or competitive pressure from Asian Paints forces rollback, prices won't stick. Margins re-compress, Q3/Q4 guidance misses again, and the stock re-tests lows.
Price increase stickiness failure
2
High
₹400 Cr inventory at peak RM costs is a working capital anchor. If Q3 demand doesn't absorb it (or if demand shifts to lower-priced competitors), inventory sits longer, ties up cash, and forces discounting that erodes margins further. WC management becomes the constraint.
Inventory normalization delay
3
Medium
Volume growth decelerated from 7.5–8% guidance to 5.6% H1 and 3% Q2. If this trend continues into Q3/Q4, pricing power alone can't offset it. Blended growth slows below double digits, and the FY27 revenue guidance (double-digit growth) is at risk.
Volume growth plateau
4
Medium
₹22 Cr extraordinary spend in Q2 is a multi-quarter bet on urban brand-building. If it doesn't translate to market share gains or fails to drive sustainable pricing power in metros, the spend looks like margin waste, not investment. Playback could extend into Q3/Q4.
Rangbanara campaign ROI misses expectations
5
Medium
Asian Paints entered industrial coatings at 5% lower pricing, now matched to industry. But if it launches newer products or expands decorative presence aggressively, Berger's pricing power erodes. Urban market (7–8% share for Berger vs. Asian Paints' scale) is most vulnerable.
Asian Paints competitive pressure intensifies
How the street sees it
The stock closed at ₹478.35 on the result date, neutral trend—no post-result pop or selloff recorded. The stock is trading above its 20-day (₹472.54) and 50-day (₹470.13) simple moving averages but below its 200-day (₹482.41), a hallmark of neutral momentum. RSI at 52.6 confirms no overbought/oversold condition. More tellingly, the stock is 34.24% below its all-time high of ₹727.45 and only 22.31% above its 52-week low. This drawdown from ATH reflects market skepticism on the recovery narrative—the current price does NOT price in a swift return to 15–17% margins or double-digit net profit growth. FII ownership ticked up marginally to 4.83% (from 4.68%), and DII rose to 11.79% (from 11.71%), but both moves are incremental; no institutional conviction is evident in the post-result action. Promoter stake at 74.98% is unchanged. Volume trend is increasing, suggesting retail attention but no institutional accumulation. The street's message is clear: show margin recovery execution, not guidance; the stock will re-rate on delivery, not promises.
What to watch next
1 · EBITDA margin trajectory in October–November
Management guided for 90% RM cost recovery by November via price increases. Watch the October sales data (if disclosed) and the gross margin trend to confirm prices are sticking. If Q3 EBITDA margin is 12–13%+, recovery is underway. If it stays 10–11%, the price increases are failing and guidance is at risk.
2 · Working capital normalization
Inventory should deplete and receivables should convert in Q3 if October sales are strong (management cited 25–30-month high sales). Watch DSO (days sales outstanding) and inventory days trends. If WC improves significantly, cash flow recovery follows, validating operational health beneath the margin noise.
3 · Volume growth inflection
Volume growth at 3% Q2 is a concern. If Q3 volume growth re-accelerates to 7–8% (festive season tailwind + price normalization driving elasticity recovery), it suggests demand is alive and the price-elasticity risk is managed. If volume stays muted (<4%), it signals structural demand deceleration, not just inventory timing.
Berger Paints Q2 FY-2027 is a story of margin compression masquerading as profit growth. Headline revenue and profit numbers look passable, but operating leverage has inverted—the 46.4% QoQ profit collapse, 360 bp gap to margin guidance, and ₹400 crore inventory anchor all signal execution challenges that pricing and brand spend alone won't resolve. Management's 15–17% margin target for Q3/Q4 is a bet on external factors (crude oil prices, price stickiness) rather than operational fixes. Recovery is plausible if October price increases stick and demand normalizes. But it's not certain.
For holders: this is a hold with high execution risk. The stock is down 34% from ATH, reflecting justified skepticism. The bull case (margin recovery in Q3/Q4 via price increases and festive demand) is real but conditional. Watch October–November data closely. If prices stick and inventory depletes, Q3 will confirm it. If not, the stock could test lower levels. For fresh investors: wait for Q3 FY-2027 results to validate the recovery narrative before adding. The single number to track from here is EBITDA margin in Q3—if it's 13%+, the thesis holds. If it stays below 11%, guidance credibility is shot.
Solid growth masked by margin collapse; pricing recovery bet
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Q2 EBITDA margin 10.8% vs. 15–17% guidance. Prior guidance not met; company betting on Q3/Q4 recovery.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Berger Paints delivered 13.2% YoY revenue growth and 5.2% PAT growth in Q2 FY27, but operating margins collapsed to 10.8% EBITDA on standalone (vs. 15–17% guidance) due to raw material inflation, peak inventory, and extraordinary ₹22 Cr marketing spend. The 46.4% QoQ PAT decline is severe. Management's confidence in Q3 margin recovery hinges on commodity prices and price increase stickiness—both uncertain in a competitive market with new entrants (Asian Paints) pressuring pricing power.
₹3200.4 Cr
Revenue · +13.2% YoY₹217.1 Cr
Reported PAT · +5.2% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Revenue growth 11.9% standalone, 13.2% consolidated
METDelivered 13.2% YoY consolidated growth on ₹3200.4 Cr
Volume growth 3% QoQ, 5.6% H1
METManagement states volume moderated due to Diwali shift to Q3 and price-sensitive category de-growth (putty, textures, enamel)
Operating margins will be quite close to 15–17% band in Q3 and Q4
MISSQ2 EBITDA margin 10.8%, well below 15–17% band; H1 EBITDA 11.6% vs 14.4% standalone (normalized)
PAT growth 5.2% consolidated H1
OVERSTATEDDelivered PAT growth 5.2% YoY on consolidated basis; Q2 standalone PAT minus 7.3%, QoQ down 46.4%
Gross margin impacted by raw material inflation; operating margin compression contained despite ₹22 Cr investment in Rangbanara
MISSGross margin 36.6% Q2 vs 38.1% H1 (2.5–3% drop); EBITDA margin dropped from 14.4% H1 to 10.8% Q2, indicating non-contained compression
Earnings quality
What changed since the last call
Margin guidance reaffirmed
NeutralPrior guidance 15–17% operating margins; Q1 achieved 17.4%. Q2 delivered 10.8%, below guidance. Management reaffirmed 15–17% for H2, betting on price increases and cost control
Revenue growth resilient
UpgradePrior guidance 'double-digit revenue growth'; Q2 delivered 13.2% YoY, slightly above low-double digits. H1 at 12.3%, solid but moderated from Q1 given volume slowdown
Volume growth decelerated
DowngradeExpected ~7.5–8% volume growth; actual was 5.6% H1, 3% Q2 QoQ due to Diwali shift and price-sensitive categories (putty, textures) de-growing
RM inflation emerged as headwind
DowngradeManagement acknowledged double-digit RM inflation not fully offset by pricing; gross margin compressed despite 8%+ price increases taken. Inventory at peak prices amplified impact
The Q&A
Analysts (Rishi Mody, Pratik Gothi, Aniruddha Joshi) pressed hard on margin recovery path, working capital, and price increases. Management held its guidance but provided limited specifics on magnitude of recoveries. Tone was defensive on inventory and receivables buildup; management framed as normal course. Confidence on margin recovery was qualified by oil-price and competitive assumptions.
Working capital & inventory — Rishi Mody, analyst
PartialOctober is peak Diwali month. Inventory buildup planned, at peak RM prices. Coupled effect of high sales and high RM costs. Q3 sales and price hikes should normalize this.
Urban penetration strategy — Aniruddha Joshi, analyst
AnsweredMEGA = Maintenance, Experiment, Grow, Accelerate. Urban experiments yielding positive results; 7–8% market share in metro cities vs. 20% all-India. Two factories planned: West Bengal (Panagar) and Orissa; using surplus cash, no debt needed. Will deploy as demand grows.
Deco & industrial margins with pricing — Pratik Gothi, HSBC
AnsweredDeco gross margin dropped 2.5–3% due to RM inflation and peak-price inventory. Took prices in Oct; expecting 90% recovery by Nov if oil prices stable. Industrial margin also pressured but offset by volume growth. Q3/Q4 should see improvement as price increases stick and inventory normalizes.
Rangbanara campaign ROI — Sushil Chavan, analyst
PartialBrand-building takes time; not a switch-on/off. Sustained spend over 7–8 months required. This is a long-term play; initial results positive. Urban markets are under-penetrated; small player there. Will continue investing to capture opportunity.
Share price and future capitalization — Shiva Kumar Marlingapar, analyst
DodgedOur job is to grow sales and bottom line. Future will be visible when we perform well. Rest is for market to decide.
Guidance
FY27 double-digit revenue growth expected to sustain
HighQ2 delivered 13.2% YoY; H1 at 12.3%. On track for double-digit FY27 growth. Management reaffirmed expectations for Q3 (festive) and Q4 given pricing and volume drivers
Operating margins 15–17% for FY27; quite confident to stay close in Q3/Q4
LowQ2 delivered 10.8% EBITDA (2.5–4% below range). Management expects recovery on price increases (90% by Nov) and crude oil price stability. But execution risk is high; volume growth is modest (5.6% H1) and competitor (Asian Paints) entered at lower pricing
CapEx ₹600–800 Cr for FY27; factories in West Bengal and Orissa
MediumNormalized working capital assumed as input stabilizes. Two factories announced; West Bengal in Panagar, Orissa at later date. Will be funded from cash reserves (net cash position maintained). Scale of investment to be decided based on government incentive policy (West Bengal announced new industrial policy)
Risks the call surfaced
Gross margin pressure
HighDouble-digit RM inflation not fully offset by price increases; Q2 gross margin 36.6% vs. 38.1% H1, down 150 bps. Peak inventory booked at high cost amplifies margin drag. Recovery hinges on oil price stability and pricing power.
Competitive intensity
MediumAsian Paints (new entrant competitor in industrial coatings) entered at 5% lower pricing; now matched to industry levels but pricing power questioned. Market share of Berger at ~20% on all-India basis but only 7–8% in metro urban markets, competing heavily there.
Working capital & inventory
MediumReceivables and inventory elevated post-Diwali. Inventory built ~400 crores at peak RM prices. If demand softens or prices don't increase as expected, inventory may not deplete smoothly, tying up cash and extending payback period.
Price increase stickiness
MediumManagement expects to recover 90% of RM cost inflation via price increases by November. But if crude oil prices spike again or volume demand weakens, price increases may not stick, and margins could re-compress.
Execution risk on new initiatives
LowRangbanara Rahe brand campaign (extraordinary ₹22 Cr spend in Q2) and new products (waterproof adhesive, decorative panels, Dam Shield) are early-stage. ROI uncertain. Urban market MEGA strategy is experimental; positive results acknowledged but scale-up timing and profitability unproven.
Management
Score 6/10. Abhijit Roy (MD & CEO) provided detailed opening remarks covering segment performance, margin drivers, and forward outlook. Q&A showed willingness to address questions but some hedging on margin recovery (qualified by oil prices, pricing stickiness). Transparency on inventory and receivables buildup was initially limited; later clarified as Diwali-driven and planned. Not fully candid on sales returns or future competitive outlook. Track record mixed in this call. Prior guidance (15–17% margins, 7.5–8% volume growth) not met in Q2 (10.8% EBITDA, 3% Q2 volume). Revenue guidance (double-digit growth) on track at 13.2% YoY. H1 PAT growth 13.2% but Q2 QoQ PAT down 46.4%, indicating execution gaps and working capital management challenges.
1 · Oct–Nov 2026
Price increases rollout; management expects 90% of margin impact recovered by November
2 · Q3 FY27
Festive season demand; historically strong quarter. October sales at 25–30-month high per management
3 · Q4 FY27
Continued margin recovery and new product adoption (waterproof adhesive, decorative panels, Dam Shield)
Management's confidence in Q3 margin recovery hinges on commodity prices and price increase stickiness—both uncertain in a competitive market with new entrants (Asian Paints) pressuring pricing power.